The Board of Directors


Julian Attfield Stravencon imageJulian AttfieldChief Financial Officer, Company Secretary and Director
Julian has 17 years of experience working as a Chief Financial and Chief Executive Officer in the global biopharmaceutical industry, and has particular expertise in working with start-ups and Chinese and Indian companies.

Julian was CFO and then CEO at GeneMedix plc, (now Reliance GeneMedix plc) , an Indian AIM-listed  (Alternate Investment Market) biopharmaceutical  company, where he developed a range of biosimilar (generic biopharmaceutical) products for registration in the EU, and set up EU approved manufacturing (EU cGMP). GeneMedix floated on the Official List of the London and Singapore Stock Exchanges, acquired and divested a business in China, and set up manufacturing joint ventures in Europe and Asia. Julian led the company into an acquisition by Reliance Life Sciences, part of the large Reliance Industries Group of India, and a move onto the AIM market.

Previously, he was Director of Finance and Administration with Sigma-Genosys Ltd, a manufacturer of biomolecules, taking them from start-up to a trade sale to Sigma Aldrich. He was recently the interim Chief Financial Officer to a portfolio of early stage companies such as Smart Holograms Ltd, a UK developer of sensor holograms for use in healthcare diagnostics.  He was UK director for the AIM flotation of BHK Inc, a Korean stem cell company.

Julian has a BA degree in Modern Languages from Exeter University and post graduate studies from Cambridge University, U.K., and qualified as a Chartered Accountant with Arthur Andersen (now part of Deloitte & Touche).
 


Douglas B Andrews Stravencon imageDouglas B Andrews
Non- Executive Director

Douglas has over 30 years of experience in the global biopharmaceutical industry, 21 of which were with the Schering-Plough Corporation, where he held a series of international roles gaining extensive experience in emerging markets such as Latin America and Eastern Europe.

Douglas’s experience has included senior management roles in international business development, product management, marketing, sales and general management. His industry experience covers prescription pharmaceuticals and biochemicals, consumer healthcare products and generics.

Douglas was also the Founder & CEO of Consilient Health Ltd., where he established an innovative European “virtual” generic pharmaceutical company, combining traditional pharmaceutical industry promotional techniques with more cutting-edge commercial and operational technologies. He also served as a member of the Investment Committee of the National Bank of Dubai Sana, advising on  investments in the Middle East, North Africa and South Asia.

Douglas has a B.A. in History from Columbia College, U.S.A, and an M.A./M.Phil. in Balkan and Russian Area Studies from Columbia University.

 

 

Venichand Harania MBE Stravencon imageVenichand Harania MBENon- Executive Director
Veni was awarded an MBE in 2002 for distinction in the profession of pharmacy. His contribution spans over four decades in manufacturing, research & development, pharmaceutical wholesaling, and community pharmacy.

He was the architect in setting up a virtual national co-operative of independent community pharmacies in early 90’s, first of its kind in the UK.  He now owns a small chain of pharmacies and mentors young pharmacists.

He graduated with B Pharm and M Pharm degrees from the University of Wales.

Thank you

Thank you





Copyright © Stravencon Limited 2010-2015. All rights reserved.
Home   |   About Us   |   Products   |   Services   |   Media Centre   |   Contact  |  Privacy  |  Terms 

English   中文      
 
Please login first
or Register
Please register
or Login
Thank you for registering.
Please check your email address and password again.
This Email address is already logged on our system. Please enter in a new one.